1. The effect of Aronia consumption on lipid profile, blood pressure, and biomarkers of inflammation: A systematic review and meta‐analysis of randomized controlled trials
- Author
-
Lenny T. Vasanthan, Jamal Rahmani, Vincent Onyeche, Cain C T Clark, Seyed Mohammad Mousavi, Theophilus Lakiang, Hamed Kord Varkaneh, and Yong Zhang
- Subjects
Adult ,Male ,medicine.medical_specialty ,Blood Pressure ,Gastroenterology ,law.invention ,03 medical and health sciences ,chemistry.chemical_compound ,0302 clinical medicine ,Randomized controlled trial ,law ,Internal medicine ,Photinia ,medicine ,Humans ,Randomized Controlled Trials as Topic ,Inflammation ,Pharmacology ,0303 health sciences ,medicine.diagnostic_test ,Triglyceride ,Cholesterol ,business.industry ,030302 biochemistry & molecular biology ,Lipids ,Blood pressure ,chemistry ,030220 oncology & carcinogenesis ,Meta-analysis ,Female ,Aronia ,Lipid profile ,business ,Biomarkers ,Lipoprotein - Abstract
Plant derivatives, such as anthocyanin-rich phytochemicals, have been reported to elicit a positive effect on lipid profile. Therefore, the aim of this study was to systematically review and meta-analyze the effects of Aronia consumption on lipid profiles, blood pressure, and biomarkers of inflammation in randomized controlled trials. A systematic search was performed in PubMed/MEDLINE, Cochrane, and SCOPUS up to December 2018. Seven studies were identified and analyzed in this meta-analysis. Our study found a significant increase in high-density lipoprotein (HDL; weighted mean difference [WMD]: 1.48 mg/dl, 95% confidence interval, CI, [1.29, 1.68]) and diastolic blood pressure (WMD: 2.55 mmHg, 95% CI [0.63, 4.47]) following Aronia consumption. There was no significant effect on systolic blood pressure and C-reactive protein, tumor necrosis factor, and interleukin-1. Furthermore, subgroup analysis showed that cholesterol (WMD: -7.18, 95% CI [-13.90, -0.46]) and low-density lipoprotein (LDL; WMD: -5.84, 95% CI [-6.91, -4.77]) decreased more significantly in interventions less than 10 weeks in duration. Dose-response analysis demonstrated a significant reduction in triglyceride levels when dose of Aronia was increased to 300 mg/day. In conclusion, the results demonstrated a significant increase in HDL and reduction in total cholesterol and LDL among patients supplementing with Aronia.
- Published
- 2019
- Full Text
- View/download PDF